share_log

Item 9 Labs (OTC:INLB) Shares Down 5.7%

Item 9 Labs (OTC:INLB) Shares Down 5.7%

項目 9 實驗室 (OTC: INLB) 股價下跌 5.7%
Defense World ·  2022/12/14 01:52

Item 9 Labs Corp. (OTC:INLB – Get Rating)'s share price fell 5.7% on Tuesday . The company traded as low as $0.25 and last traded at $0.25. 33,714 shares traded hands during trading, an increase of 73% from the average session volume of 19,515 shares. The stock had previously closed at $0.27.

項目 9 實驗室公司(OTC:INLB-獲取評級)的股價下跌 5.7% 週二.該公司的交易價格低至 0.25 美元,最後交易價為 0.25 美元。33,714 股在交易過程中交易手數,較 19,515 股平均交易量上升 73%。該股票之前已收盤 0.27 美元。

Item 9 Labs Stock Down 5.7 %

項目 9 實驗室庫存下降 5.7%

The firm has a market cap of $24.42 million, a P/E ratio of -1.00 and a beta of 0.33. The business's fifty day moving average price is $0.30 and its two-hundred day moving average price is $0.53. The company has a current ratio of 0.14, a quick ratio of 0.04 and a debt-to-equity ratio of 0.02.

該公司的市值為 2442 萬美元,市盈率為 -1.00,貝塔值為 0.33。該企業的五十天移動平均價格為 0.30 美元,其 200 天移動平均價格為 0.53 美元。該公司的流動比率為 0.14,快速比率為 0.04,債務與權益比率為 0.02。

Item 9 Labs Company Profile

項目 9 實驗室公司簡介

(Get Rating)

(取得評分)

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona.

項目 9 實驗室公司在美國作為垂直整合的大麻運營商和藥房特許經營商。該公司生產各種類別的大麻和大麻相關產品,例如花; 濃縮物; 蒸餾物; 和硬件。它通過許可的藥房向亞利桑那州的消費者提供大麻和大麻衍生的產品和技術。

See Also

另請參閱

  • Get a free copy of the StockNews.com research report on Item 9 Labs (INLB)
  • We Are the Champions: 3 Dividend Growers Wall Street Loves
  • Will Nordstrom Stock be the Grinch This Year?
  • Harpoon Therapeutics Remains Volatile After Promising News
  • What is Market Structure in Trading?
  • Institutional Selling Is No Headwind For Nike
  • 獲取有關第 9 項實驗室(INLB)的免費研究報告
  • 我們是冠軍:3 股息種植者華爾街愛
  • 諾德斯特龍股票今年會成為聖誕嗎?
  • 魚叉治療在有希望的消息後仍然不穩定
  • 什麼是交易中的市場結構?
  • 機構銷售對耐克來說沒有逆風

Receive News & Ratings for Item 9 Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Item 9 Labs and related companies with MarketBeat.com's FREE daily email newsletter.

每天接收項目 9 實驗室的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收有關第 9 項實驗室和相關公司的最新新聞和分析師評級的簡要每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論